Podcast Interview with Dr. D. Ross Camidge and Dr. David Gerber of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), and Dr. David Gerber, one of the founding members of ATOMIC, and Associate Professor of Internal Medicine within the Hematology/Oncology Division at UT Southwestern Medical Center, discuss how a liberal arts education can serve as a foundation for a successful medical career, the benefits of face-to-face, personalized patient connections versus digital interactions, and the value in keeping a humble and service-focused approach when providing patient care.

Dr. Camidge is a distinguished leader in lung cancer research and care, serving as the Director of Thoracic Oncology at the University of Colorado, as well as Professor of Medicine/Oncology and the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado. Dr. Camidge also leads our Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), noting that “ATOMIC brings together a powerful mixture of mature thought leaders and the next generation of experts with the sole goal of designing and completing clinical trials that will change the way we do business in thoracic oncology for the better.”

Dr. Gerber’s research has generated more than 100 publications that he has authored or co-authored, including articles, abstracts, book chapters, book reviews, and invited manuscripts. In addition to serving as an Associate Professor, Dr. Gerber is the Co-Director of the Experimental Therapeutics Program at UT Southwestern Medical Center.

Listen to the podcast below:

 

Recommended Posts